Not available
Quote | Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)
Last: | $ |
---|---|
Change Percent: | -2.92% |
Open: | $3.07 |
Close: | $2.99 |
High: | $3.08 |
Low: | $2.91 |
Volume: | 688,797 |
Last Trade Date Time: | 12/05/2019 04:21:57 pm |
News | Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)
Foamix Pharmaceuticals Ltd (FOMX) Q4 2020 Earnings Conference Call March 4, 2021 08:30 ET Company Participants Michael Wood - Investor Relations Dave Domzalski - President and Chief Executive Officer Matt Wiley - Chief Commercial Officer Andrew Saik - Chief Financial Officer Iain Stuart - Chi...
Foamix Pharmaceuticals (FOMX): Q4 Non-GAAP EPS of -$0.43; GAAP EPS of -$0.55.Revenue of $4.29M (+2964.3% Y/Y)Press Release For further details see: Foamix Pharmaceuticals reports Q4 results
Message Board Posts | Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)
Subject | By | Source | When |
---|---|---|---|
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating | realfast95 | investorshub | 03/09/2020 1:24:43 PM |
$FOMX closed at 4pm at 3.14 on 3/6 | realfast95 | investorshub | 03/06/2020 9:06:54 PM |
Strike one against the merger being a successful one | pickspicks1 | investorshub | 02/27/2020 11:36:56 AM |
UGH! | pickspicks1 | investorshub | 02/27/2020 11:03:13 AM |
$MNLO failed phase 2 | realfast95 | investorshub | 02/26/2020 12:38:25 PM |
Foamix Pharmaceuticals Ltd. Company Name:
FOMX Stock Symbol:
NASDAQ Market:
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address ...
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address ...
REHOVOT, Israel, BRIDGEWATER, N.J. and REDWOOD CITY, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) and Menlo Therapeutics Inc. (Nasdaq: MNLO) today announced that the shareholders of Foamix and stockholders of Menlo voted to approve all shareholder and...